Brain monitor study aims to ensure organ donation safety

NCT ID NCT05884736

First seen May 19, 2026

Summary

This study monitors brain activity and blood flow in organ donors during a procedure called abdominal normothermic regional perfusion. The goal is to confirm that brain function does not restart after death is declared. Researchers will use brain wave and ultrasound monitors on 30 donors to provide safety evidence for this donation technique.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ORGAN TRANSPLANT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • London Health Sciences Centre

    RECRUITING

    London, Ontario, N6A 5A5, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Toronto Western Hospital

    NOT_YET_RECRUITING

    Toronto, Ontario, M5T 2S8, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could confirm that the donation procedure is safe and does not restart brain activity, helping standardize the technique.

What could go wrong

This is a small, early study with only 30 participants. It is observational and not testing a treatment, so it may not change practice on its own.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.